Project Number 2P01AG015379-21A1 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Project 3-Mechanistic Studies of Novel Gamma Secretase Modulators Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 1. Amyloid beta d. Secretases Researcher and Organization Principal Investigator TANZI, RUDOLPH EMILE Principal Investigator First Name RUDOLPH Principal Investigator Last Name TANZI Awardee Organization BRIGHAM AND WOMEN'S HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-030: NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional) FY Overall Cost $433,295 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YANG, AUSTIN JYAN-YU Related Resources Repository [AlzPED] Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606.
